Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine

Area of Science:

• Neurovirology
• Neuropsychology
• Infectious Diseases

Background:

• Hepatitis C virus (HCV) infection is a global health concern.
• Comorbidities like HIV infection and methamphetamine (METH) dependence are common in certain populations.
• Neurocognitive dysfunction is a recognized complication in these comorbid conditions.

Purpose of the Study:

• To investigate the specific contribution of HCV infection to neurocognitive deficits.
• To assess the impact of HCV in individuals with co-occurring HIV infection or METH dependence.
• To determine if HCV exacerbates cognitive impairment in at-risk populations.

Main Methods:

• A cohort of 430 participants was studied, including normal controls and individuals with HCV, HIV, METH dependence, or combinations thereof.
• Comprehensive neurocognitive functioning was assessed across multiple domains.
• Statistical analyses were performed to identify predictors of neuropsychological impairment.

Main Results:

• Neuropsychological impairment increased with the number of risk factors (HCV, HIV, METH).
• HCV serostatus significantly predicted global NP performance, learning, abstraction, and motor skills.
• Trends suggested HCV also affected speeded processing and delayed recall, but not attention or verbal fluency.

Conclusions:

• Hepatitis C virus infection is an independent contributor to neuropsychological deficits.
• HCV exacerbates cognitive impairment in HIV-infected and stimulant-dependent populations.
• Understanding HCV's role is crucial for managing cognitive health in these vulnerable groups.